POELLATH advises Maxburg Capital Partners on acquisition of MLase AG

The investment company Maxburg Beteiligungen IV GmbH & Co. KG (“Maxburg”), advised by Maxburg Capital Management GmbH, has acquired a stake in MLase AG (“MLase”), a leading global provider of UV light-based medical and industrial products. Along with MLase’s management, Maxburg will continue to drive the continued growth of the company. POELLATH provided tax advice to Maxburg in connection with the acquisition.

MLase, founded in 2007 and based in Germering near Munich, develops and produces innovative and high-quality laser and light systems for medical technology. These products are an integral part of numerous OEM systems used in refractive eye surgery, angiology and glaucoma treatment, among others. The company’s customer base includes notable OEM customers from the medical sector.

Maxburg is an investment management company focused on the German-speaking region that primarily supports companies in partnership to drive sustainable growth. MLase is the third investment of Maxburg’s latest fund, launched in summer 2022.

POELLATH advised Maxburg on all tax issues within the context of the acquisition with the following Munich team:

• Gerald Herrmann (partner, lead, tax)
• Jannis Lührs (associate, tax)